175
Views
18
CrossRef citations to date
0
Altmetric
Review

Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature

, , , &
Pages 1085-1097 | Published online: 23 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Suheda Ozcakir, Deniz Sigirli, Ahmet Ursavas & Esra Uzaslan. (2020) COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2441-2448.
Read now
Iacopo Chiodini, Daniela Merlotti, Alberto Falchetti & Luigi Gennari. (2020) Treatment options for glucocorticoid-induced osteoporosis. Expert Opinion on Pharmacotherapy 21:6, pages 721-732.
Read now

Articles from other publishers (16)

Yu-Lin Tsai, Hao-Ping Wang, Da-Wei Wu, Jiun-Chi Huang, Pei-Yu Wu & Szu-Chia Chen. (2023) Low Lung Function Is Associated with Low Baseline Calcaneus Ultrasound T-Score but a Slow Decline in T-Score in a Taiwanese Follow-Up Population with No History of Smoking, Bronchitis, Emphysema, or Asthma. Journal of Personalized Medicine 13:5, pages 795.
Crossref
Amelia GROSSO, Isa CERVERI, Lucia CAZZOLETTI, Maria E. ZANOLIN, Veronica MATTIOLI, Davide PILONI, Erica GINI, Federica ALBICINI, Vanessa RONZONI, Debbie JARVIS, Christer JANSON & Angelo G. CORSICO. (2023) Inhaled corticosteroids and risk of osteoporosis in late-middle-aged subjects: a multicenter European cohort study. Minerva Medica 114:1.
Crossref
Lorenzo Lippi, Arianna Folli, Claudio Curci, Francesco D’Abrosca, Stefano Moalli, Kamal Mezian, Alessandro de Sire & Marco Invernizzi. (2022) Osteosarcopenia in Patients with Chronic Obstructive Pulmonary Diseases: Which Pathophysiologic Implications for Rehabilitation?. International Journal of Environmental Research and Public Health 19:21, pages 14314.
Crossref
Yun Zheng, Jing Xia & Jisheng Zheng. (2022) Application of Acupoint Catgut Embedding Therapy Combined with Liuzijue Breathing Exercise in the Treatment of Patients with Stable Chronic Obstructive Pulmonary Disease. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-9.
Crossref
Han-Shuo Hu, Zhuo Wang, Li-Mei Zhao & Xiao-Dong Liu. (2022) Nebulized corticosteroids versus systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials. Frontiers in Pharmacology 13.
Crossref
Alessandro de Sire, Lorenzo Lippi, Vittorio Aprile, Dario Calafiore, Arianna Folli, Francesco D’Abrosca, Stefano Moalli, Marco Lucchi, Antonio Ammendolia & Marco Invernizzi. (2022) Pharmacological, Nutritional, and Rehabilitative Interventions to Improve the Complex Management of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease: A Narrative Review. Journal of Personalized Medicine 12:10, pages 1626.
Crossref
Xilan Zhang, Guangying Wang, Dayue Shen, Yating Feng, Yan Zhang, Chao Zhang, Yuanping Li & Hui Liao. (2022) Protective effects of budesonide on LPS‑induced podocyte injury by modulating macrophage M1/M2 polarization: Evidence from in vitro and in silico studies . Experimental and Therapeutic Medicine 24:3.
Crossref
Yue Ma, Shui Qiu & Renyi Zhou. (2022) Osteoporosis in Patients With Respiratory Diseases. Frontiers in Physiology 13.
Crossref
José Luis Lopez-Campos, Pere Almagro, José Tomás Gómez, Eusebi Chiner, Leopoldo Palacios, Carme Hernández, M. Dolores Navarro, Jesús Molina, David Rigau, Juan José Soler-Cataluña, Myriam Calle, Borja G. Cosío, Ciro Casanova & Marc Miravitlles. (2022) [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care. Archivos de Bronconeumología 58:4, pages T334-T344.
Crossref
José Luis Lopez-Campos, Pere Almagro, José Tomás Gómez, Eusebi Chiner, Leopoldo Palacios, Carme Hernández, M. Dolores Navarro, Jesús Molina, David Rigau, Juan José Soler-Cataluña, Myriam Calle, Borja G. Cosío, Ciro Casanova & Marc Miravitlles. (2022) Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos. Archivos de Bronconeumología 58:4, pages 334-344.
Crossref
Nicolas Roche, Philippe Devillier, Patrick Berger, Arnaud Bourdin, Daniel Dusser, Jean-François Muir, Yan Martinat, Philippe Terrioux & Bruno Housset. (2021) Individual trajectory-based care for COPD: getting closer, but not there yet. ERJ Open Research 7:4, pages 00451-2021.
Crossref
Garu A, Shozo Yano, Abdullah Md Sheik, Aorigele Yu, Kenta Okuyama, Miwako Takeda, Kunie Kohno, Masayuki Yamasaki, Minoru Isomura, Toru Nabika & Atsushi Nagai. (2021) Effect of Multimorbidity on Fragility Fractures in Community-Dwelling Older Adults: Shimane CoHRE Study. Journal of Clinical Medicine 10:15, pages 3225.
Crossref
Marc Miravitlles, Ariadna Auladell-Rispau, Mònica Monteagudo, Juan Carlos Vázquez-Niebla, Jibril Mohammed, Alexa Nuñez & Gerard Urrútia. (2021) Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. European Respiratory Review 30:160, pages 210075.
Crossref
Christer Janson, Karin Lisspers, Björn Ställberg, Gunnar Johansson, Florian S. Gutzwiller, Karen Mezzi, Linda Mindeholm, Bine Kjoeller Bjerregaard, Leif Jorgensen & Kjell Larsson. (2021) Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study. European Respiratory Journal 57:2, pages 2000515.
Crossref
James N. Cole, Rohini A. Mathur & Sally A. Hull. (2020) Reducing the use of inhaled corticosteroids in mild-moderate COPD: an observational study in east London. npj Primary Care Respiratory Medicine 30:1.
Crossref
Rui‑Xiong Huang & Jun Tao. (2020) Nicotinamide mononucleotide attenuates glucocorticoid‑induced osteogenic inhibition by regulating the SIRT1/PGC‑1α signaling pathway. Molecular Medicine Reports 22:1, pages 145-154.
Crossref